About Technology Issues FAQ

Links

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.